Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise. | World J Hepatol | 2023 | 36744169 | PubTator, text mining | PubMed |
| Bulky magnesium(ii) and sodium(i) bisphenoxide catalysts for chemoselective transesterification of methyl (meth)acrylates. | Chem Sci | 2023 | 36741511 | PubTator, text mining | PubMed |
| Role of FGF10/FGFR2b Signaling in Homeostasis and Regeneration of Adult Lacrimal Gland and Corneal Epithelium Proliferation. | Invest Ophthalmol Vis Sci | 2023 | 36715672 | PubTator, text mining | PubMed |
| Brønsted acid catalyzed mechanochemical domino multicomponent reactions by employing liquid assisted grindstone chemistry. | Sci Rep | 2023 | 36697475 | PubTator, text mining | PubMed |
| Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study. | Lancet Oncol | 2023 | 36681091 | PubTator, text mining | PubMed |
| Primary and Metastatic Cutaneous Melanomas Discriminately Enrich Several Ligand-Receptor Interactions. | Life (Basel) | 2023 | 36676129 | PubTator, text mining | PubMed |
| The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues-A Status Report. | Int J Mol Sci | 2023 | 36674567 | PubTator, text mining | PubMed |
| Pathology of Combined Hepatocellular Carcinoma-Cholangiocarcinoma: An Update. | Cancers (Basel) | 2023 | 36672443 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Reductive Elimination Reactions in Gold(III) Complexes Leading to C(sp3)-X (X = C, N, P, O, Halogen) Bond Formation: Inner-Sphere vs SN2 Pathways. | Inorg Chem | 2023 | 36658748 | PubTator, text mining | PubMed |
| Controlling organoid symmetry breaking uncovers an excitable system underlying human axial elongation. | Cell | 2023 | 36657443 | PubTator, text mining | PubMed |
| Efficient generation of ETX embryoids that recapitulate the entire window of murine egg cylinder development. | Sci Adv | 2023 | 36652512 | PubTator, text mining | PubMed |
| Whole-exome sequencing of rectal neuroendocrine tumors. | Endocr Relat Cancer | 2023 | 36645718 | PubTator, text mining | PubMed |
| Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide. | Molecules | 2023 | 36615533 | PubTator, text mining | PubMed |
| High expression level of homocitrulline is correlated with seborrheic keratosis and skin aging. | An Bras Dermatol | 2023 | 36610814 | PubTator, text mining | PubMed |
| Tooth number abnormality: from bench to bedside. | Int J Oral Sci | 2023 | 36604408 | PubTator, text mining | PubMed |
| Electrochemical reactor dictates site selectivity in N-heteroarene carboxylations. | Nature | 2023 | 36603811 | PubTator, text mining | PubMed |
| HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. | JCO Precis Oncol | 2023 | 36603172 | PubTator, text mining | PubMed |
| Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors. | Oncoimmunology | 2023 | 36545254 | PubTator, text mining | PubMed |
| Fgf8 promotes survival of nephron progenitors by regulating BAX/BAK-mediated apoptosis. | Differentiation | 2023 | 36527791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=14